Created with Sketch.
HeartSuccess- A Heart Failure Podcast
108 minutes | Feb 15, 2021
#27 AHA 2020 Trials
We discuss several of the important data coming out the American Heart Association 2020 meeting. Thanks for listening. Please like, subscribe and give us a rating.
84 minutes | Jan 9, 2021
#26 Cardiorenal Protection with Newer Antidiabetic Agents
We have a multispecialty panel discussion on the cardiorenal benefits of newer antidiabetic agents with Drs Rangaswami, Vaduganathan, Tuttle and Bhalla. Thanks for listening. Please like, subscribe and give us a rating.
94 minutes | Dec 21, 2020
#25 ESC 2020 Trials
We discuss several of the important data coming out the European Society of Cardiology 2020 meeting. Thanks for listening. Please like, subscribe and give us a rating.
46 minutes | Sep 26, 2020
#24 Cardiogenic Shock Case Discussion
We discuss cardiogenic shock and decision making in the case of a young female presenting to the ER. We have a panel of cardiologists guide the discussion. Drs Rene Alvarez, Daniel Sims and Alec Vishnevski discuss the case presented by cardiology fellow Rachna Kataria, MD. Thanks for listening. Please like, subscribe and give us a rating.
54 minutes | Aug 18, 2020
#23 Understanding Cardiogenic Shock with Navin Kapur MD
We discuss the various aspects of cardiogenic shock including definition, heterogeneity, classification and management with an internationally renowned expert in the field Dr Navin Kapur. Dr Kapur is the Director of the Acute Mechanical Circulatory Support Program at Tufts University School of Medicine, Boston, MA. Listen, like, subscribe, and give us a high rating.
62 minutes | Aug 2, 2020
#22 Cardio-Oncology from the Cardiologist- Cardiotoxicity with Sherry-Ann Brown MD PhD
We discuss several aspects of cardio-oncology including screening protocols, specific chemotherapy related cardiotoxicities and management of cardiovascular disease among cancer patients and cancer survivors. Dr Sherry-Ann Brown is the director of Cardio-Oncology at the Medical College of Wisconsin, Milwaukee, WI. Listen, like, subscribe, and give us a high rating.
42 minutes | Jul 19, 2020
#21 Cardio-Oncology- Arrhythmias in Cancer Patients with Michael Fradley MD and Avirup Guha MD
We discuss several aspects of cardiac arrhythmias and their management among cancer patients and cancer survivors with Drs Fradley and Guha. Dr Fradley is an electrophysiologist and Dr Guha is a non-invasive cardiologist, both with tremendous expertise in cardio-oncology. Dr Fradley is the Medical Director of Cardio-Oncology at University of Pennsylvania, Philadelphia, PA. Listen, like, subscribe, and give us a high rating.
41 minutes | Jul 15, 2020
#20 Cardio-Oncology from the Radiation Oncologist- Radiation Therapy and Cardiovascular Disease with Brett Lewis MD PhD
We discuss some radiation physics, role for ionizing radiation in treating cancer & related cardiac damage with Dr Brett Lewis MD PhD. Dr. Lewis has interest & expertise in treating several thoracic malignancies & practices at Hackensack Meridian Health, NJ. Listen, like, subscribe, and give us a high rating.
49 minutes | Jun 10, 2020
#19 Cardio-Oncology from the Oncologist- Cancer Therapy and Cardiovascular Toxicity with Kaushal Parikh, MD
We discuss several classes of cancer therapies including chemotherapy, immunotherapy, CAR T-Cell therapies and related cardiovascular toxicity from the perspective of a board certified oncologist Dr Kaushal Parikh, MD. Dr Parikh specializes in thoracic oncology and practices at Hackensack Meridian Health, NJ. Listen, Like, Subscribe, and give us a high rating!
84 minutes | May 21, 2020
#18 ACC 2020 Trials
We review and discuss a lot of exciting data including late-breaking trials from the American College of Cardiology Scientific Sessions in March, 2020. Listen, Like, Subscribe, and give us a high rating!
43 minutes | May 13, 2020
#17 Inpatient HFrEF & HFpEF management with Carolyn Lam MBBS PhD
We review the inpatient management in HFrEF, role of GDMT initiation & HF exacerbating drugs. We end the episode with a discussion on HFpEF & device therapies with Professor Carolyn Lam, a Senior Consultant of the National Heart Centre, Singapore and Professor of Duke-NUS Cardiovascular Academic Clinical Program. Listen, Like, Subscribe, and give us a rating!
60 minutes | Mar 26, 2020
#16 COVID-19 Cardiovascular Update with Jennifer Haythe, MD
We discuss Coronavirus Disease 2019 and cardiovascular involvement. Dr Jennifer Haythe, a Heart Failure cardiologist from Columbia University Medical Center talks about the cardiovascular sequelae associated with COVID-19 and related management. We end with HCW protection, appropriate PPE, new data of HCQ and investigational therapies. Listen, Like, Subscribe, and give us a rating!
40 minutes | Mar 22, 2020
#15 COVID-19 UPDATE with Udit Chaddha, MD
We discuss Coronavirus Disease 2019 in the USA. Dr Udit Chaddha, a Pulmonary Disease & Critical Care specialist from the Icahn School of Medicine - Mount Sinai Hospital in New York talks about the virus, disease identification, healthcare worker protection and management of related acute respiratory illness. Listen, Like, Subscribe, and give us a rating!
64 minutes | Mar 14, 2020
#14 Transthyretin (ATTR) amyloidosis with Mathew Maurer, MD
We discuss transthyretin (aTTR) cardiac amyloidosis, symptoms, appropriate diagnostic testing and different treatment options available. Dr. Mathew Maurer from NewYork-Presbyterian Hospital/Columbia University shares his expertise with us. Listen, Like, Subscribe, and give us a rating!
50 minutes | Feb 29, 2020
#13 Light chain amyloidosis with Ronald Witteles, MD
Management of light chain or AL amyloidosis has changed with major advances in recent years. Dr. Ronald Witteles is a Stanford Cardiologist with particular expertise in the treatment of cardiac amyloidosis and shares his expertise with us. He serves as Co-Director of the Stanford Amyloid Center, one of the world's leading amyloid centers. Listen, Like, Subscribe, and give us a rating!
43 minutes | Feb 4, 2020
#12 Sudden Cardiac Death in Heart Failure with Nasrien Ibrahim, MD
Sudden cardiac death in heart failure has changed as therapies have evolved. We discuss arrhythmic and non arrhythmic sudden death in heart failure, and how we can lower its incidence. Dr Nasrien Ibrahim MD from Massachusetts General Hospital affiliated with Harvard Medical School shares her expertise. Listen, Like, Subscribe, and give us a rating!
52 minutes | Jan 19, 2020
#11 Diabeto-Cardiology: From the Cardiologist's perspective with Muthiah Vaduganathan, MD
Diabetes management is evolving and we discuss the role of cardiologists in improving cardio-metabolic care. Dr Muthiah Vaduganathan MD MPH from Brigham and Women's Hospital & Harvard Medical School shares his expertise on the evidence for newer drugs and how cardiologists can get engaged in diabetes management. This is episode three of four in our Diabeto-Cardiology series. Listen, Like, Subscribe, Tweet and don't forget to give us a Rating!!
94 minutes | Dec 12, 2019
#10 AHA 2019 trials and Apple Heart Study
Big trials presented at AHA 2019!! We have two interviews and we discuss ISCHEMIA, ISCHEMIA CKD, COLCOT, ORION-10, BETonMACE, AVR in asymptomatic very severe AS, GALILEO, DAPA-HF, and the Apple Heart study. Listen, Like, Subscribe and don't forget to give us a Rating!!
47 minutes | Nov 14, 2019
#9 Diabeto-Cardiology: From the Endocrinologist's perspective with Ritika Puri, MD
Diabetes management is changing rapidly, and with that we have newer management strategies with cardiovascular benefit. Dr Ritika Puri shares an endocrinologist's perspective on where diabetes stands today, and shares interesting insights into how to approach cardiovascular disease in diabetes management. This is episode two of four in our Diabeto-Cardiology series. Listen, Like, Subscribe and don't forget to give us a Rating!!
33 minutes | Oct 31, 2019
#8 Diabeto-Cardiology: Let's get to know the diabetic drugs with Ilya Danelich PharmD
Ilya Danelich PharmD (Board Certified Cardiac Pharmacist) walks us through the mechanism of action and pearls for different classes of diabetic drugs including the NEWER drugs. We also describe how to prescribe the newer SGLT2 inhibitors and review mechanisms for adverse effects and cardiovascular/renal benefits. This is episode one of four in our Diabeto-Cardiology series. Listen, Like, Subscribe and don't forget to give us a Rating!!
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021